Table 3.
Factors associated with CA-AKI and HA-AKI
| Bivariate |
Multivariate |
|||
|---|---|---|---|---|
| OR (95% CI) | p value | HR (95% CI) | p value | |
| CA-AKI | ||||
| Charlson Comorbidity Index, per point | 1.47 (1.34–1.61) | <0.001 | 1.16 (1.02–1.32) | 0.020 |
| CKD, versus no | 8.02 (3.83–16.8) | <0.001 | 4.17 (1.53–11.3) | 0.005 |
| Hypertension, versus no | 2.44 (1.79–3.32) | <0.001 | 1.55 (1.01–2.36) | 0.043 |
| SOFA score, per point | 2.71 (2.34–3.14) | <0.001 | 2.19 (1.87–2.57) | <0.001 |
| Glucose at admission, per 10 mg/dL | 1.07 (1.05–1.08) | <0.001 | 1.04 (1.03–1.06) | <0.001 |
| Creatine kinase, per 10 U/dL | 1.05 (1.02–1.09) | 0.005 | 1.06 (1.01–1.12) | 0.021 |
| C-reactive protein, per mg/dL | 1.08 (1.06–1.09) | <0.001 | 1.04 (1.02–1.06) | <0.001 |
| Troponin I >ULN, versus no | 5.41 (3.78–7.75) | <0.001 | 1.91 (1.20–3.05) | 0.006 |
| HA-AKI | ||||
| BMI, per kg/m2 | 1.07 (1.04–1.10) | <0.001 | 1.04 (0.99–1.09) | 0.053 |
| Glucose at admission, per 10 mg/dL | 1.05 (1.03–1.07) | <0.001 | 1.05 (1.02–1.08) | 0.002 |
| Troponin I >ULN, versus no | 3.61 (2.29–5.69) | <0.001 | 1.95 (1.01–3.83) | 0.046 |
| Intubation, versus no | 77.5 (42.9–140) | <0.001 | 68.2 (37.1–126) | <0.001 |
ARB, angiotensin receptor blocker; CA-AKI, community-acquired acute kidney injury; HA-AKI, hospital-acquired acute kidney injury; SOFA, sequential organ failure assessment score; ULN, upper limit of normal.